相关实验视频

Updated: Jun 21, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

免疫检查点抑制剂介导心肌炎:心脏中的CTLA4,PD1和LAG3

Amir Z Munir¹, Alan Gutierrez^1,2, Juan Qin¹

¹Section of Cardio-Oncology & Immunology, Cardiovascular Research Institute (CVRI), University of California San Francisco, School of Medicine, San Francisco, CA, USA.

Nature reviews. Cancer

|July 9, 2024

概括

免疫检查点抑制剂 (ICI) 可以导致心肌炎,一种严重的心脏炎症. 了解ICI心肌炎机制是癌症患者更好的诊断和治疗的关键.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
心脏病学心脏病学

背景情况:

免疫检查点抑制剂 (ICI) 广泛用于癌症治疗,使患者有资格接受治疗.
影响任何器官的免疫相关毒性对接受ICI治疗的患者构成风险.
ICI介导心肌炎 (ICI心肌炎) 是ICI治疗的罕见但可能致命的并发症.

研究的目的:

审查ICI心肌炎的基本和机制方面.
综合从临床前模型和患者样本中获得的最新数据.
探索如何理解免疫检查点生物学可以改善诊断和治疗.

主要方法:

审查现有的文献和数据.
临床前研究结果的综合.
对患者样本数据的分析.

主要成果:

由于ICI使用量增加和组合疗法增加,ICI心肌炎是一个新兴的临床问题.
了解免疫检查点的基本生物学对于推进ICI-心肌炎研究至关重要.
目前对心脏免疫检查点的知识有限,但越来越多.

结论:

对ICI心肌炎的机制性洞察力可以导致改进的诊断和治疗策略.
需要对ICI心肌炎病理生理学的进一步研究,以更好地分层患者的风险.
通过更好的理解,可以开发基于ICI心肌炎的精确疗法.

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.